PubMed Health⌕ Search

Biomedical subjects

C S Kleinman

Publications and source records attributed to C S Kleinman.

97 records · Page 6Linked to original sources
PubMedDate not supplied

Cardiac arrhythmias in the human fetus.

Fetal cardiac arrhythmias have been recognized with increasing frequency during the past several years. Most fetal arrythmias are intermittent extrasystoles, often presenting as irregular pauses of rhythm. These are significant only when they occur with appropriate timing to initiate sustained tachycardia, mediated by anatomic bypass pathways. The most common important fetal arrhythmias are: 1) supraventricular tachycardias, and 2) severe bradyarrhythmias, associated with complete heart block. Symptomatic fetal tachycardias are usually supraventricular in origin, and may be associated with the developmet of hydrops fetalis. These patients may respond to antiarrhythmic drug therapy, administered via maternal ingestion or via direct fetal injection. Such therapy should be offered with careful fetal and maternal monitoring, and must be based on a logical, sequential analysis of the electrical mechanism underlying the arrhythmia, and an appreciation of the pharmacology and pharmacokinetics of the maternal, placental fetal system. Bradycardia from complete heart block may either be associated with complex congential heart malformations involving the atrioventricular junction of the heart, or may present in fetuses with normal cardiac structure, in mothers with autoimmune conditions associated with high titres of anti-SS-A or anti-SS-B antibody, which cross the placenta to cause immune-related inflammatory damage to the fetal atroventricular node. This paper reviews experience with the analysis of fetal caridac rhythm, a detailed discussion of the pathophysiology of arrhythmias and their effect on the fetal circulatory system, and offers a logical framework for the construction of treatment algorithms for fetuses at risk for circulatory compromise from fetal arrhythmias.

Algorithms↗
PubMedDate not supplied

Echocardiographic guidance of catheter-based treatments of atrial septal defect: transesophageal echocardiography remains the gold standard.

The availability of echocardiographic imaging to the catheterization laboratory has been recognized as an essential component of every congenital heart program for almost 30 years. The imaging data that are uniquely available using this technique may be used to plan the catheterization procedure; to add insights regarding valve anatomy and chordal insertions and myocardial performance; to assist in the identification of pericardial effusions; and to provide additional guidance for the performance of pericardiocentesis.

Cardiac Catheterization↗
PubMedDate not supplied

Inhaled nitric oxide therapy in a critically ill neonate with Ebstein's anomaly.

The successful use of nitric oxide (NO) inhalation in a critically ill neonate with Ebstein's anomaly of the tricuspid valve is reported for the first time. This use of inhaled NO therapy suggests a therapeutic intervention that directly addresses the pathophysiologic process of severe neonatal Ebstein's anomaly.

Administration, Inhalation↗
PubMedDate not supplied

Fetal echocardiography--applications and limitations.

Fetal echocardiography has been a useful technique for demonstrating the anatomy of the developing human heart. M-mode echocardiography may be used to provide rhythm diagnosis in the absence of high-fidelity transabdominal fetal electrocardiograms. The information so generated may be applied to plan the management of pregnancy and delivery in a population at "high risk" for structural or functional heart disease and may provide the impetus for developing in utero treatment programs. For this reason, a high degree of sensitivity and specificity must be asked of the technique and of the personnel performing the examination. "Major" malformations which impart marked hemodynamic and structural alterations on the fetal heart may be reliably diagnosed. Diseases which must be identified on the basis of direct recognition of subtle abnormalities of structure, with little impact on fetal flow patterns (e.g. mild semilunar valve stenosis of perimembranous ventricular septal defect) have been more problematic. Before effective screening and treatment programs for the fetal heart can be developed, a cooperative effort between cardiologists and perinatologists is essential in order to gain facility with imaging as well as familiarity with the natural history of these conditions.

Echocardiography↗
PubMedDate not supplied

Doppler echocardiography in the human fetus.

Fetal echocardiography has allowed prenatal diagnosis of heart disease to become a reality over the last decade. Recently, pulsed Doppler flow studies have been applied to the examination of the fetal cardiovascular system. In fetuses with dysrhythmias, complex structural heart malformations, nonimmune hydrops fetalis, or mothers receiving nonsteroidal prostaglandin synthetase inhibitors, pulsed Doppler echocardiographic studies are clinically indicated. These studies involve noninvestigational tests that provide information of critical clinical import. These studies may occasionally, require energy intensities that exceed the 510(k) limits. The physician should be held responsible for educating patients to the potential risks versus benefits of any imaging study they undergo, but appending potentially alarming labels to transducers, machines, or cathode-ray tube displays can only serve to undermine the fabric of the physician-patient relationship without achieving the desired goal of protection of the patient.

Echocardiography, Doppler↗